Servier

Industry · 7 registered clinical trials.

Status	Trial	Phase	Started
Active Not Recruiting	Phase 3 Study of Vorasidenib (S095032/AG-881) in Asian Participants With Residual or Recurrent Grade 2 Glioma Residual or Recurrent Grade 2 IDH Mutant Glioma	Phase 3	2024-10-18
Active Not Recruiting	A Phase 2 Study of Ivosidenib in Previously Treated Japanese Subjects With Nonresectable or Metastatic Cholang Cholangiocarcinoma Non-resectable, Cholangiocarcinoma Metastatic	Phase 2	2023-10-10
Completed	Non-drug Treatment Study in Parkinson's Disease Patients and Healthy Volunteers to Collect Biological Samples Parkinson Disease	EARLY_Phase 1	2022-07-11
Terminated	An Experimental Medicine Clinical Study to Compare Peripheral Immune System From Subjects Without Cancer Diagn Immune System	N/A	2021-11-25
Completed	Trifluridin/tipirACil in MeTastatIc Colorectal Cancer Metastatic Colorectal Cancer	—	2018-06-25
Completed	Evaluation of the Clinical Efficacy and Safety of Amlodipine 5mg/ Bisoprolol Fumarate 5mg /Perindopril Arginin Essential Hypertension	Phase 3	2018-05-14
Approved For Marketing	Vorasidenib Expanded Access Program Glioma, Recurrence, Disease Attributes	—	—